Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Association of mitochondrial DNA transversion mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome

Oncogene volume 25, pages 677–684 (2006)Cite this article

Abstract

Medullary thyroid carcinoma (MTC) is a malignant tumour of the calcitonin-secreting parafollicular C cells of the thyroid, and occurs sporadically or as a component of the multiple endocrine neoplasia (MEN) type 2/familial medullary thyroid carcinoma (FMTC) syndromes. In the present study, we investigated the frequency of mtDNA mutations in 26 MTC tumour specimens (13 sporadic and 13 familial MTC) and their matched normal tissues by sequencing the entire coding regions of mitochondrial genome. Nonsynonymous mutations were detected in 20 MTC samples (76.9%): nine out of 13 sporadic MTC (69.2%) and 11 out of 13 (84.6%) familial MTC/MEN2. Both transition and transversion types of mutations were found in the samples. Interestingly, 76.2% (16/21) of transversion mutations were found in FMTC/MEN2 patients, whereas 66.7% (12/18) of transition mutations were in sporadic MTC. Synonymous mutations were found in 12 MTC samples. In total, we identified 27 transversion mutations (21 nonsynonymous and six synonymous) in MTC. Of them, 22 (81.5%) were from FMTC/MEN2, and five (18.5%) were from sporadic MTC. The association of transversion mutation with familial MTC/MEN2 was statistically significant (P=0.0015, binomial test). Majority of the mutations were involved in the genes located in the complex I of the mitochondrial genome, and were often resulting in a change of a moderately or highly conserved amino acid of their corresponding protein. Mitochondrial respiratory function was also compromised in a TT cell line, which carries mtDNA mutation at nt 4917 and 11 720, and in peripheral lymphocytes of MTC patients with mtDNA mutations. These data suggest that mtDNA mutation may be involved in MTC tumourigenesis and progression. Given that mtDNA mutation spectra are different between sporadic and familial MTC, different mechanisms of oxidative DNA damage may occur in the disease process.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  • Abu-Amero KK, Alzahrani AS, Zou M, Shi Y . (2005). Oncogene 24: 1455–1460.

  • Abu-Amero KK, Bosley TM . (2005). Arch Pathol Lab Med 129: 62–65.

  • Astuti D, Douglas F, Lennard TW, Aligianis IA, Woodward ER, Evans DG et al. (2001). Lancet 357: 1181–1182.

  • Benn DE, Croxson MS, Tucker K, Bambach CP, Richardson AL, Delbridge L et al. (2003). Oncogene 22: 1358–1364.

  • Bogenhagen DF, Pinz KG, Perez-Jannotti RM . (2001). Prog Nucleic Acid Res Mol Biol 68: 257–271.

  • Bourgeron T, Chretien D, Poggi-Bach J, Doonan S, Rabier D, Letouze P et al. (1994). J Clin Invest 93: 2514–2518.

  • Chinnery PF, Schon EA . (2003). J Neurol Neurosurg Psychiatry 74: 1188–1199.

  • Coller HA, Khrapko K, Bodyak ND, Nekhaeva E, Herrero-Jimenez P, Thilly WG . (2001). Nat Genet 28: 147–150.

  • Cooke MS, Evans MD, Dizdaroglu M, Lunec J . (2003). FASEB J 17: 1195–1214.

  • De Vita G, Melillo RM, Carlomagno F, Visconti R, Castellone MD, Bellacosa A et al. (2000). Cancer Res 60: 3727–3731.

  • Elisei R, Cosci B, Romei C, Bottici V, Sculli M, Lari R et al. (2004). J Clin Endocrinol Metab 89: 3579–3584.

  • Elson JL, Samuels DC, Turnbull DM, Chinnery PF . (2001). Am J Hum Genet 68: 802–806 (Epub 2001 February 6).

  • Eng C, Kiuru M, Fernandez MJ, Aaltonen LA . (2003). Nat Rev Cancer 3: 193–202.

  • Farid NR, Zou M, Shi Y . (1995). Endocrinol Metab Clin North Am 24: 865–883.

  • Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM et al. (2000). Science 287: 2017–2019.

  • Girelli ME, Nacamulli D, Pelizzo MR, De Vido D, Mian C, Piccolo M et al. (1998). Thyroid 8: 517–523.

  • Hansford JR, Mulligan LM . (2000). J Med Genet 37: 817–827.

  • Harris AL . (2002). Nat Rev Cancer 2: 38–47.

  • Hartman P, Ponder R, Lo HH, Ishii N . (2004). Mech Ageing Dev 125: 417–420.

  • Hundahl SA, Fleming ID, Fremgen AM, Menck HR . (1998). Cancer 83: 2638–2648.

  • Ishii T, Yasuda K, Akatsuka A, Hino O, Hartman PS, Ishii N . (2005). Cancer Res 65: 203–209.

  • Jones JB, Song JJ, Hempen PM, Parmigiani G, Hruban RH, Kern SE . (2001). Cancer Res 61: 1299–1304.

  • Kang D, Hamasaki N . (2003). Clin Chem Lab Med 41: 1281–1288.

  • Kato M, Iwashita T, Takeda K, Akhand AA, Liu W, Yoshihara M et al. (2000). Mol Biol Cell 11: 93–101.

  • Kino K, Sugiyama H . (2001). Chem Biol 8: 369–378.

  • Kino K, Sugiyama H . (2005). Mutat Res 571: 33–42 (Epub 2005 January 25).

  • Kiuru M, Launonen V . (2004). Curr Mol Med 4: 869–875.

  • Klaunig JE, Kamendulis LM . (2004). Annu Rev Pharmacol Toxicol 44: 239–267.

  • Kurokawa K, Kawai K, Hashimoto M, Ito Y, Takahashi M . (2003). J Intern Med 253: 627–633.

  • LeDoux SP, Wilson GL . (2001). Progr Nucleic Acid Res Mol Biol 68: 273–284.

  • Ludwig L, Kessler H, Wagner M, Hoang-Vu C, Dralle H, Adler G et al. (2001). Cancer Res 61: 4526–4535.

  • Mandavilli BS, Santos JH, Van Houten B . (2002). Mutat Res 509: 127–151.

  • Marsh DJ, Mulligan LM, Eng C . (1997). Horm Res 47: 168–178.

  • Massoll N, Mazzaferri EL . (2004). Clin Lab Med 24: 49–83.

  • Maximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Simoes M . (2002). Am J Pathol 160: 1857–1865.

  • Mazzaferri EL . (1993). N Engl J Med 328: 553–559.

  • Myers SM, Mulligan LM . (2004). Cancer Res 64: 4453–4463.

  • Neeley WL, Delaney JC, Henderson PT, Essigmann JM . (2004). J Biol Chem 279: 43 568–43 573 (Epub 2004 August 6).

  • Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD et al. (1998). Nat Genet 20: 291–293.

  • Punales MK, Graf H, Gross JL, Maia AL . (2003). J Clin Endocrinol Metab 88: 2644–2649.

  • Ramensky V, Bork P, Sunyaev S . (2002). Nucleic Acids Res 30: 3894–3900.

  • Rieder MJ, Taylor SL, Tobe VO, Nickerson DA . (1998). Nucleic Acids Res 26: 967–973.

  • Santoro M, Melillo RM, Carlomagno F, Vecchio G, Fusco A . (2004). Endocrinology 145: 5448–5451 (Epub 2004 August 26).

  • Segouffin-Cariou C, Billaud M . (2000). J Biol Chem 275: 3568–3576.

  • Shi Y, Parhar RS, Zou M, Hammami MM, Akhtar M, Lum ZP et al. (1999). Br J Cancer 79: 1234–1239.

  • Shi YF, Zou MJ, Schmidt H, Juhasz F, Stensky V, Robb D et al. (1991). Cancer Res 51: 2690–2693.

  • Shidara Y, Yamagata K, Kanamori T, Nakano K, Kwong JQ, Manfredi G et al. (2005). Cancer Res 65: 1655–1663.

  • Simonnet H, Alazard N, Pfeiffer K, Gallou C, Beroud C, Demont J et al. (2002). Carcinogenesis 23: 759–768.

  • Slupphaug G, Kavli B, Krokan HE . (2003). Mutat Res 531: 231–251.

  • Stevnsner T, Thorslund T, de Souza-Pinto NC, Bohr VA . (2002). Exp Gerontol 37: 1189–1196.

  • Tomlinson IP, Alam NA, Rowan AJ, Barclay E, Jaeger EE, Kelsell D et al. (2002). Nat Genet 30: 406–410 (Epub 2002 February 25).

  • Wallace DC . (1999). Science 283: 1482–1488.

  • Yeh JJ, Lunetta KL, van Orsouw NJ, Moore Jr FD, Mutter GL, Vijg J et al. (2000). Oncogene 19: 2060–2066.

  • Zhang HX, Du GH, Zhang JT . (2004). Acta Pharmacol Sin 25: 385–389.

Download references

Author information

Authors and Affiliations

  1. Department of Genetics, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

    K K Abu-Amero, M Zou & Y Shi

  2. Department of Medicine, King Faisal Specialist Hospital and Research Center, Riyadh, Saudi Arabia

    A S Alzahrani

Authors
  1. K K Abu-Amero
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A S Alzahrani
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M Zou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Y Shi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Y Shi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abu-Amero, K., Alzahrani, A., Zou, M. et al. Association of mitochondrial DNA transversion mutations with familial medullary thyroid carcinoma/multiple endocrine neoplasia type 2 syndrome. Oncogene 25, 677–684 (2006). https://doi.org/10.1038/sj.onc.1209094

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1209094

Keywords

This article is cited by

Search

Advanced search

Quick links